ts and 85 percent of the non-obese patients were available for evaluation. In general, the obese patients had moderately lower functional improvements and higher levels of routine hip pain. However, patient satisfaction with the result of their revision THA was gauged to be about the same in both groups.
As its lead author, Dr. Anne Lbbeke, acknowledges, this study is limited by the relatively small number of adverse events resulting in large confidence intervals and restricting the adjustment for baseline differences between obese and non-obese patients to the most important confounding factors. Despite such weaknesses, the findings reinforce revision THA as a technically-challenging intervention, particularly when performed on obese patients.
Surgeons, patients, and referring physicians should be aware of an increased risk in this patient group, Dr. Lbbeke stresses. Further studies are necessary to evaluate whether changes in medical preparation, surgical technique, and implant choice can help reduce the adverse event rate in obese patients undergoing revision THA.
'/>"/>
Page: 1 2 3 Related medicine news :1.
How to manage Chinese obese children with non-alcoholic fatty liver disease?2.
Aspirin-like compounds increase insulin secretion in otherwise healthy obese people3.
Obese women disadvantaged in both breast cancer treatment and diagnosis4.
Obese Women Less Likely to Be Tested for Some Cancers5.
Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise6.
Breast cancer more aggressive among obese women7.
Obese Children Face More Complications During Surgery8.
Overweight and obese men have lower PSA values, even before they get prostate cancer9.
Born to Be Obese?10.
Bone mineral content continues to increase in obese adolescents during weight loss11.
Anti-Inflammatory Drug Improves Glycemia, Lowers Inflammation in Obese, Young Adults